Ovid Therapeutics Inc (NASDAQ:OVID)

3.48
Delayed Data
As of 3:59pm ET
 -0.03 / -0.85%
Today’s Change
1.41
Today|||52-Week Range
3.89
+87.10%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$261.6M

Company Description

Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.

Contact Information

Ovid Therapeutics, Inc.
441 9th Avenue
New York New York 10001
P:(646) 661-7661
Investor Relations:
(917) 943-6681

Employees

Shareholders

Mutual fund holders7.59%
Other institutional48.50%
Individual stakeholders30.89%

Top Executives

Jeremy Max LevinChairman, President & Chief Executive Officer
Jason TardioChief Operating Officer
Jeffrey A. RonaChief Financial & Business Officer
Claude NicaiseHead-Research & Development
Julia TsaiSenior VP-Clinical Development & Medical Affairs